Search Within

Karen Anne Autio

Formats
  1. Meeting Abstract (77)
  2. Journal Article (41)
  3. Review (3)
Groups
  1. Department of Medicine (121)
  2. Genitourinary Oncology Service (121)
  3. Solid Tumor Oncology Division (121)
  4. Hematologic Malignancies, Division of (30)
  5. GSK Faculty (21)
  6. Epidemiology and Biostatistics (14)

More Groups

People
  1. Howard Scher (47)
  2. Michael Morris (36)
  3. Dana Rathkopf (34)
  4. Susan Slovin (28)
  5. Daniel Danila (23)
  6. Wassim Abida (15)

More People

Years
  1. 2025 (6)
  2. 2024 (6)
  3. 2023 (7)
  4. 2022 (7)
  5. 2021 (7)
  6. 2020 (8)

More Years

Publications
  1. Journal of Clinical Oncology (48)
  2. Annals of Oncology (18)
  3. Journal for ImmunoTherapy of Cancer (11)
  4. Clinical Cancer Research (8)
  5. Journal of Immunotherapy and Precision Oncology (3)
  6. Cancer (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (50)
  2. Oxford University Press (18)
  3. Biomed Central Ltd (11)
  4. American Association for Cancer Research (10)
  5. Elsevier Inc. (5)
  6. Elsevier Science, Inc. (5)

More Publishers

Results (121)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pegylated interleukin-10: Clinical development of an immunoregulatory cytokine for use in cancer therapeutics
    Review

    Autio, K.; Oft, M.
    Current Oncology Reports (2019)

    Fulltext@MSK | Save
  • Pegilodecakin with nivolumab (nivo) or pembrolizumab (pembro) in patients (pts) with metastatic renal cell carcinoma (RCC)
    Meeting Abstract

    Tannir, N. M.; Naing, A.; Infante, J. R.; Papadopoulos, K. P.; Wong, D. J. L.; Korn, M.; Aljumaily, R.; Autio, K. A.; Pant, S.; Bauer, T. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Preliminary interim results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic (Pb-Tx) CX-072 in combination with ipilimumab (ipi) in patients (pts) with advanced solid tumors
    Meeting Abstract

    Sanborn, R. E.; Menke, C. W.; Autio, K. A.; Arkenau, H. T.; Corbacho, J. G.; LoRusso, P.; Plummer, E. R.; Uboha, N. V.; Freeman, M. L.; Wydmanski, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • c15-160: Enzalutamide (ENZA) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1b Prostate Cancer Clinical Trials Consortium study
    Meeting Abstract

    Rathkopf, D. E.; Autio, K. A.; Antonarakis, E. S.; Cheng, H. H.; Arauz, G.; Slack, A.; Hullings, M.; Scher, H. I.; Feng, F. Y.; Knudsen, K. E.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Overall survival of PEGylated pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Hecht, J. R.; Naing, A.; Falchook, G. S.; Patel, M. R.; Infante, J. R.; Aljumaily, R.; Wong, D. J. L.; Autio, K. A.; Wainberg, Z. A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Responses and durability in NSCLC treated with pegilodecakin and anti-PD-1
    Meeting Abstract

    Garon, E. B.; Schneider, J. G.; Wong, D. J. L.; Aljumaily, R.; Korn, W. M.; Infante, J. R.; Patel, M. R.; Autio, K. A.; Papadopoulos, K. P.; Naing, A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Phase 2, randomized, 3-arm study of abiraterone acetate and prednisone (AAP), AAP plus degarelix (AAP plus D), and degarelix (D) alone for patients (pts) with biochemically-recurrent prostate cancer (PC) following radical prostatectomy (RP)
    Meeting Abstract

    Autio, K. A.; Antonarakis, E. S.; Mayer, T. M.; Vaishampayan, U. N.; Shevrin, D. H.; Harrison, M. R.; Tagawa, S. T.; Milowsky, M. I.; Graff, J. N.; Beer, T. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Preliminary results of the first-in-human, dose-finding PROCLAIM-CX-072 trial of the PD-L1 Probody therapeutic CX-072 as monotherapy in patients (pts) with advanced solid tumors
    Meeting Abstract

    Autio, K. A.; Arkenau, H. T.; O'Neil, B. H.; Bendell, J. C.; El-Khoueiry, A.; Strauss, J.; Weise, A.; Uboha, N. V.; Rizvi, N. A.; Zheng, B.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Microsatellite instability in prostate cancer and response to immune checkpoint blockade
    Meeting Abstract

    Abida, W.; Cheng, M. L.; Armenia, J.; Middha, S.; Autio, K. A.; Rathkopf, D. E.; Morris, M. J.; Danila, D. C.; Slovin, S. F.; Carbone, E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Overall survival of PEGylated human IL-10 (AM0010) with 5-FU/LV and oxaliplatin (FOLFOX) in metastatic pancreatic adenocarcinoma (PDAC)
    Meeting Abstract

    Hecht, J. R.; Naing, A.; Falchook, G. S.; Patel, M. R.; Infante, J. R.; Aljumaily, R.; Wong, D. J. L.; Autio, K. A.; Wainberg, Z. A.; Javle, M. M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save